Announcements Trials
Browse Landscape

Phase

Phase 1 49Phase 2 29Phase 1/2 22Phase 3 9Phase NA 4Phase EARLY_PHASE1 2Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 27Other hematologic neoplasm 21Breast 13Plasma cell 4Sarcoma 2Myeloid 2Other 1Genitourinary 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Wilms Tumor 1

Interventions

Zoledronic Acid 15enzalutamide 10Leuprolide 9Goserelin 8bicalutamide 7acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6Triptorelin Pamoate 6Prednisone 6Nivolumab 6Abiraterone Acetate 6luprolide acetate gel depot 5Sunitinib 5Magnetic Resonance Spectroscopy 5Everolimus 5Dutasteride 5Specimen Handling 4Sodium Chloride 4Propofol 4Prednisolone 4Androgen Antagonists 42-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 4pazopanib 3fluciclovine F-18 3darolutamide 3cabazitaxel 3Trimethoprim, Sulfamethoxazole Drug Combination 3Rocuronium 3Mitomycin 3Midazolam 3Flutamide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Cyclophosphamide × Genitourinary × Clear all
NCT03892330 2019-03-27

Combination Therapy of Anthracyclines for Children With Nephroblastoma

Shengjing Hospital

Phase 4 Not yet recruiting
120 enrolled
Genitourinary

Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡